来曲唑在乳腺癌中的应用。 - Suppr

Suppr

超能文献

Letrozole in breast cancer.

作者信息

Shahab Nasir

出版信息

N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.

PMID:14971058

Abstract

摘要

相似文献

Letrozole in breast cancer.

N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.

Letrozole after tamoxifen for breast cancer--what is the price of success?

N Engl J Med. 2003 Nov 6;349(19):1855-7. doi: 10.1056/NEJMe038167. Epub 2003 Oct 9.

[Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].

Suppl Tumori. 2004 Jul-Aug;3(4):S25-6.

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

N Engl J Med. 2003 Nov 6;349(19):1793-802. doi: 10.1056/NEJMoa032312. Epub 2003 Oct 9.

Adjuvant aromatase inhibitors: are we there yet?

Cancer. 2003 Nov 1;98(9):1779-81. doi: 10.1002/cncr.11746.

Anti-tumor effects of letrozole.

Cancer Invest. 2002;20 Suppl 2:15-21. doi: 10.1081/cnv-120014882.

Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.

N Engl J Med. 2003 Nov 6;349(19):1857-9. doi: 10.1056/NEJMe038174. Epub 2003 Oct 9.

[Endocrine therapy of causation: role of aromatase inhibitors in breast cancer].

Tumori. 2003 Nov-Dec;89(6):21-8. doi: 10.1177/030089160308900622.

Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.

J Surg Oncol. 1997 Nov;66(3):215-20. doi: 10.1002/(sici)1096-9098(199711)66:3<215::aid-jso11>3.0.co;2-0.

[Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study].

Suppl Tumori. 2004 Jul-Aug;3(4):S27-31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Letrozole in breast cancer.

N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.

Letrozole after tamoxifen for breast cancer--what is the price of success?

N Engl J Med. 2003 Nov 6;349(19):1855-7. doi: 10.1056/NEJMe038167. Epub 2003 Oct 9.

[Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].

Suppl Tumori. 2004 Jul-Aug;3(4):S25-6.

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

N Engl J Med. 2003 Nov 6;349(19):1793-802. doi: 10.1056/NEJMoa032312. Epub 2003 Oct 9.

Adjuvant aromatase inhibitors: are we there yet?

Cancer. 2003 Nov 1;98(9):1779-81. doi: 10.1002/cncr.11746.

Anti-tumor effects of letrozole.

Cancer Invest. 2002;20 Suppl 2:15-21. doi: 10.1081/cnv-120014882.

Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.

N Engl J Med. 2003 Nov 6;349(19):1857-9. doi: 10.1056/NEJMe038174. Epub 2003 Oct 9.

[Endocrine therapy of causation: role of aromatase inhibitors in breast cancer].

Tumori. 2003 Nov-Dec;89(6):21-8. doi: 10.1177/030089160308900622.

Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.

J Surg Oncol. 1997 Nov;66(3):215-20. doi: 10.1002/(sici)1096-9098(199711)66:3<215::aid-jso11>3.0.co;2-0.

[Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study].

Suppl Tumori. 2004 Jul-Aug;3(4):S27-31.

Letrozole in breast cancer.

作者信息

Shahab Nasir

出版信息

N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.

PMID:14971058

Abstract

摘要